Retraction notice to Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine [Seminars Nucl Med 55 (2025) 648-663] [0.03%]
关于“放射示踪未来：非FDG放射示踪剂核医学”的撤稿声明[Seminars Nucl Med 55 (2025) 648-663]
Giuseppe Arturo Fuso,Gianfilippo Bianciardi,Riccardo Mei et al.
Giuseppe Arturo Fuso et al.
Practical approach to diuretic renography in children: Techniques, interpretation, and pitfalls [0.03%]
儿童利尿肾图检查实践：技术、解读及陷阱
Reza Vali,Amer Shammas,Neha Kwatra et al.
Reza Vali et al.
Diuretic renography remains central to evaluating suspected urinary tract obstruction in children, yet interpretation varies across centers. Modern pediatric practice benefits from standardized acquisition and analysis, including harmonized...
Ishita Sen,Dharmender Malik,Parul Thakral
Ishita Sen
Prostate cancer remains a major global health burden, and the integration of PSMA-targeted PET imaging and radioligand therapy has transformed diagnostic and therapeutic strategies for advanced disease. Traditional response assessment tools...
18F-FDG PET/CT for prediction of response in breast cancer [0.03%]
18F-FDG正电子发射断层扫描/X线计算机体层成像对乳腺癌治疗反应的预测价值
Mariza Vorster,Mike Sathekge
Mariza Vorster
Breast cancer remains one of the most heterogeneous malignancies, with marked variability in biology, therapeutic sensitivity, and clinical outcomes. As treatment strategies evolve toward individualized approaches, early and accurate assess...
Artificial intelligence in nuclear cardiology: Technical perspectives, strategic directions, and recommendations from an IAEA expert working group [0.03%]
人工智能在核心脏病学中的应用：国际原子能机构专家工作组的技术视角、战略方向和建议
Christiane Wiefels,Luis Eduardo Juárez-Orozco,Pietro Selemo Craviolatti et al.
Christiane Wiefels et al.
Artificial intelligence (AI) is increasingly permeating nuclear cardiology and offers the possibility to enhance diagnostic accuracy, prognostic stratification, and operational efficiency. AI is demonstrating applicability across the imagin...
Sophie C Siegmund,Emil Novruzov,Eduards Mamlins et al.
Sophie C Siegmund et al.
FAP-ligands as novel cancer radiopharmaceuticals in nuclear medicine have been recently translated successfully into the clinical space. Particularly small molecules (i.e. FAPI-46, FAPI-74) and peptides (i.e. FAP-2286, DOTAGA.SA.FAPi) seem ...
Scintigraphy as an ancillary examination in determination of death by neurologic criteria: Update and future perspectives [0.03%]
脑死亡判定中放射性核素显像辅助检查的现状与未来展望
Lionel S Zuckier
Lionel S Zuckier
The concept of death by neurologic criteria (DNC), a medicolegal construct also known as "brain death", is over 50 years old. Ancillary examinations have a well-defined role in this diagnosis, principally when the clinical examination canno...
The value of PSMA PET for risk stratification in prostate cancer: an update and future aspects [0.03%]
PSMA PET在前列腺癌风险分层中的价值：更新和未来展望
Caner Civan,Madeleine J Karpinski,Kambiz Rahbar et al.
Caner Civan et al.
PSMA-PET has become a pivotal imaging method for staging and restaging of prostate cancer. Risk stratification of the disease is a crucial for the patients to receive most appropriate treatment, and for the clinicians to follow the patients...
Hossein Jadvar,Amir Iravani
Hossein Jadvar
Metastatic prostate cancer heterogeneity is a multifactorial spatiotemporally dynamic process that leads to disease progression, emergence of treatment resistance and eventual treatment failure. Understanding of the root causes of tumor het...